Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomx Ltd (PHGE)

Biomx Ltd (PHGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomx Ltd 22 EINSTEIN ST. 4TH FLOOR NESS ZIONA L3 7414003 ISR

www.biomx.com P: 972-72-394-2377

Description:

BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel.

Key Statistics

Overview:

Market Capitalization, $K 19,327
Enterprise Value, $K 14,657
Shares Outstanding, K 55,220
Annual Sales, $ 0 K
Annual Net Income, $ -26,170 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,490 K
EBIT, $ -25,350 K
EBITDA, $ -23,910 K
60-Month Beta 1.36
% of Insider Shareholders 4.21%
% of Institutional Shareholders 40.57%
Float, K 52,895
% Float 95.79%
Short Volume Ratio 0.23

Growth:

1-Year Return 40.67%
3-Year Return -94.95%
5-Year Return -96.45%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 04/03/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 38.46%
EPS Growth vs. Prev Year 60.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PHGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -242.05%
Return-on-Assets % -74.37%
Profit Margin % 0.00%
Debt/Equity 3.63
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.01
Book Value/Share 0.07
Interest Coverage -9.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar